Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.

Source:http://linkedlifedata.com/resource/pubmed/id/10439367

Download in:

View as

General Info

PMID
10439367